Abstract
The changes of middle molecular substances (MMS) in a group of 13 patients with acute renal failure of various origin were determined by gel filtration on Sephadex G 15.
The concentrations of plasma middle molecular substances increased rapidly during the oliguric phase and decreased during the diuretic phase of acute renal failure. However, it was significantly higher than in the controls. The concentration of MMS in the convalescent phase was still increased. In the oliguric phase of acute renal failure, before and 4 hours after haemodialysis a direct dependence was found between fraction 5 and serum urea. In the oliguric phase, this occurred between fraction 6 and serum urea. In the diuretic phase a direct dependence was demonstrated between fraction 4 and serum urea, as well as serum creatinine.
It was found that MMS are contributing to the development of uraemic syndrome in acute renal failure.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Asaba, H., Bergstrőm, J., Fűrst, P., Gunnarson, B., Neuhauser, M., Oules, R., Yahiel, V.: Removal of endogenous middle molecules by hemoperfusion.Artif. Organs, 3, 132 (1979).
Asaba, H., Fűrst, P., Oules, R., Yahiel, V., Zimmerman, L., Bergstrőm, J.: The effect of hemodialysis on endogenous middle molecules in uremic patients.Clin. Nephrol., 11, 257 (1979).
Babb, A. A., Johansen, P. J., Strand, M. J., Tenckoff, H., Scribner, B. H.: Bi-directional permeability of the human peritoneum to middle molecules.Proc. EDTA, 10, 247 (1973).
Bergstrőm, J., Fűrst, P., Zimmerman, L.: Uremic middle molecules exist and are biologically active.Clin. Nephrol., 11, 229 (1979).
Božek, P., Daněková, H., Dzúrik, R., Řezníček, J.: Mean molecular substance volume in the sera of patients with renal failure during regular dialysis treatment.Bioch. clin. bohemoslov., 4, 17 (1975).
Božek, P., Dzúrik, R., Daněková, H., Řezníček, J., Zvara, V.: Mean molecular substance volume in the sera of patients after kidney transplant operation.Čas. Lék. čes., 116, 52 (1977).
Božek, P., Erben, J., Zahradník, J., Dzúrik, R.: Serum and ultrafiltrate middle molecules in hemodialysed patients.Int. J. Urol. Nephrol. (in press).
Dzúrik, R., Božek, P., Řezníčěk, J., Oberníková, A.: Blood level of middle molecular substances during uraemia and haemodialysis.Proc. EDTA, 10, 263 (1973).
Hanicki, Z., Sarnecka-Keller, M., Klein, A., Slizowska, K.: Middle-sized ninhydrin-positive molecules in uraemic patients treated by repeated hemodialysis. I. Preliminary characteristics.Clin. Chim. Acta, 54, 47 (1974).
Lutz, W.: Chemical composition and rate of passage across semipermeable membranes of basic peptides isolated from peritoneal dialysis fluid from patients with chronic renal failure.Acta Med. Pol., 17, 137 (1976).
Lutz, W., Madry, K., Grande, G.: “Middle molecules” in acute experimental uremia.Acta Med. Pol., 19, 417 (1978).
Richterich, R.: Clinical Chemistry. Academic Press, New York 1969.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mydlík, M., Spustová, V., Dzúrik, R. et al. Middle molecular substances in acute renal failure. International Urology and Nephrology 14, 67–73 (1982). https://doi.org/10.1007/BF02082386
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02082386